Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Current Medicinal Chemistry|August 22, 2006
Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical reviewT Scior, S J Garcés-EiseleClinical and Laboratory Haematology|July 29, 1998
Molecular follow-up of patients with promyelocytic leukaemia treated with all-trans retinoic acidG J Ruiz-Argüelles, J Garcés-Eisele, A Ruiz-ArgüellesAmerican Journal of Hematology|January 12, 1999
Primary thrombophilia in Mexico: a prospective studyG J Ruiz-Argüelles, S González-Estrada, J Garcés-Eisele, et al.The Journal of Rheumatology|December 1, 1996
Inherited activated protein C resistance in a patient with familial primary antiphospholipid syndromeD Alarcón-Segovia, G J Ruiz-Argüelles, J Garcés-Eisele, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1996
Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndromeG J Ruiz-Argüelles, J Garcés-Eisele, D Alarcón-Segovia, et al.American Journal of Hematology|June 28, 2001
Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizosG J Ruiz-Argüelles, J Garcés-Eisele, V Reyes-Núñez, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
The G20210A polymorphism in the 3'-untranslated region of the prothrombin gene in Mexican mestizo patients with primary antiphospholipid syndromeG J Ruiz-Argüelles, J Garcés-Eisele, G J Ruiz-Delgado, et al.Leukemia & Lymphoma|June 5, 1998
Tuberculosis-associated fatal hemophagocytic syndrome in a patient with lymphoma treated with fludarabineG J Ruiz-Argüelles, D Arizpe-Bravo, J Garcés-Eisele, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|August 11, 2001
Molecular monitoring of the treatment of patients with BCR/ABL (+) chronic myelogenous leukemiaG J Ruiz-Argüelles, B López-Martínez, J M Ramírez-Cabrera, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 26, 2001
Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindredG J Ruiz-Argüelles, J Garcés-Eisele, V Reyes-Núñez, et al.Pageof 2